These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20381328)

  • 1. Opposing positive and negative regulation of T cell activity during viral persistence.
    Fahey LM; Brooks DG
    Curr Opin Immunol; 2010 Jun; 22(3):348-54. PubMed ID: 20381328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of IL-10 in regulating immunity to persistent viral infections.
    Wilson EB; Brooks DG
    Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into type I interferon and the immunopathogenesis of persistent viral infections.
    Snell LM; Brooks DG
    Curr Opin Immunol; 2015 Jun; 34():91-8. PubMed ID: 25771184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy and Mammalian Viruses: Roles in Immune Response, Viral Replication, and Beyond.
    Paul P; Münz C
    Adv Virus Res; 2016; 95():149-95. PubMed ID: 27112282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T cell repertoire in infection and vaccination: implications for control of persistent viruses.
    Davenport MP; Price DA; McMichael AJ
    Curr Opin Immunol; 2007 Jun; 19(3):294-300. PubMed ID: 17433874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell exhaustion during persistent viral infections.
    Kahan SM; Wherry EJ; Zajac AJ
    Virology; 2015 May; 479-480():180-93. PubMed ID: 25620767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.
    Brooks DG; Lee AM; Elsaesser H; McGavern DB; Oldstone MB
    J Exp Med; 2008 Mar; 205(3):533-41. PubMed ID: 18332180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection.
    Brooks DG; McGavern DB; Oldstone MB
    J Clin Invest; 2006 Jun; 116(6):1675-85. PubMed ID: 16710479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How chronic viral infections impact on antigen-specific T-cell responses.
    Frebel H; Richter K; Oxenius A
    Eur J Immunol; 2010 Mar; 40(3):654-63. PubMed ID: 20077405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection.
    Garidou L; Heydari S; Truong P; Brooks DG; McGavern DB
    J Virol; 2009 Sep; 83(17):8905-15. PubMed ID: 19553326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection.
    Brooks DG; Ha SJ; Elsaesser H; Sharpe AH; Freeman GJ; Oldstone MB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20428-33. PubMed ID: 19075244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Ecosystem of Virus-Infected Host Tissues.
    Maarouf M; Rai KR; Goraya MU; Chen JL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of antiviral T cell responses by type I interferons.
    Crouse J; Kalinke U; Oxenius A
    Nat Rev Immunol; 2015 Apr; 15(4):231-42. PubMed ID: 25790790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses.
    Crawford A; Wherry EJ
    Curr Opin Immunol; 2009 Apr; 21(2):179-86. PubMed ID: 19264470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression.
    Schneider-Schaulies S; Dittmer U
    J Gen Virol; 2006 Jun; 87(Pt 6):1423-1438. PubMed ID: 16690907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive and negative regulation of cellular immune responses in physiologic conditions and diseases.
    Viganò S; Perreau M; Pantaleo G; Harari A
    Clin Dev Immunol; 2012; 2012():485781. PubMed ID: 22548114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy and antiviral immunity.
    Lee HK; Iwasaki A
    Curr Opin Immunol; 2008 Feb; 20(1):23-9. PubMed ID: 18262399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections.
    Ha SJ; West EE; Araki K; Smith KA; Ahmed R
    Immunol Rev; 2008 Jun; 223():317-33. PubMed ID: 18613845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.
    Cunningham CR; Champhekar A; Tullius MV; Dillon BJ; Zhen A; de la Fuente JR; Herskovitz J; Elsaesser H; Snell LM; Wilson EB; de la Torre JC; Kitchen SG; Horwitz MA; Bensinger SJ; Smale ST; Brooks DG
    PLoS Pathog; 2016 Jan; 12(1):e1005356. PubMed ID: 26808628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.